发布求助
文献互助 智能选刊 最新文献

Clinical Advances in Hematology & Oncology最新文献

筛选
英文 中文
New drugs for relapsed or refractory multiple myeloma. 治疗复发或难治性多发性骨髓瘤的新药。
IF 1.1
Clinical Advances in Hematology & Oncology Pub Date : 2026-03-01
Benjamin Derman
{"title":"New drugs for relapsed or refractory multiple myeloma.","authors":"Benjamin Derman","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":51585,"journal":{"name":"Clinical Advances in Hematology & Oncology","volume":"24 2","pages":"89-92"},"PeriodicalIF":1.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147718575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimal treatment for metastatic HER2+ breast cancer. 转移性HER2+乳腺癌的最佳治疗方法。
IF 1.1
Clinical Advances in Hematology & Oncology Pub Date : 2026-03-01
Sara M Tolaney
{"title":"Optimal treatment for metastatic HER2+ breast cancer.","authors":"Sara M Tolaney","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":51585,"journal":{"name":"Clinical Advances in Hematology & Oncology","volume":"24 2","pages":"106-108"},"PeriodicalIF":1.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147718601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When will circulating tumor DNA be ready for prime time in lymphoma? 在淋巴瘤中，循环肿瘤DNA何时准备好？
IF 1.1
Clinical Advances in Hematology & Oncology Pub Date : 2026-03-01
Mark Roschewski
{"title":"When will circulating tumor DNA be ready for prime time in lymphoma?","authors":"Mark Roschewski","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":51585,"journal":{"name":"Clinical Advances in Hematology & Oncology","volume":"24 2","pages":"109-111"},"PeriodicalIF":1.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147718764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of LGR5 in epithelial cancer. LGR5在上皮癌中的作用。
IF 1.1
Clinical Advances in Hematology & Oncology Pub Date : 2026-03-01
Justine Y Bruce
{"title":"The role of LGR5 in epithelial cancer.","authors":"Justine Y Bruce","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":51585,"journal":{"name":"Clinical Advances in Hematology & Oncology","volume":"24 2","pages":"102-104"},"PeriodicalIF":1.1,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147718563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The evolution of treatment for uveal melanoma. 葡萄膜黑色素瘤的治疗进展。
IF 1.1
Clinical Advances in Hematology & Oncology Pub Date : 2026-01-01
Shaheer A Khan
{"title":"The evolution of treatment for uveal melanoma.","authors":"Shaheer A Khan","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":51585,"journal":{"name":"Clinical Advances in Hematology & Oncology","volume":"24 1","pages":"43-45"},"PeriodicalIF":1.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146259943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fixed-duration vs continuous treatment for chronic lymphocytic leukemia in the CLL17 trial. CLL17试验中慢性淋巴细胞白血病的固定持续治疗vs持续治疗
IF 1.1
Clinical Advances in Hematology & Oncology Pub Date : 2026-01-01
Othman Al-Sawaf
{"title":"Fixed-duration vs continuous treatment for chronic lymphocytic leukemia in the CLL17 trial.","authors":"Othman Al-Sawaf","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":51585,"journal":{"name":"Clinical Advances in Hematology & Oncology","volume":"24 1","pages":"34-36"},"PeriodicalIF":1.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146259692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The clinical applications of next-generation sequencing and ctDNA/cfDNA in lymphoma. 新一代测序及ctDNA/cfDNA在淋巴瘤中的临床应用。
IF 1.1
Clinical Advances in Hematology & Oncology Pub Date : 2026-01-01
Andrew Ip, Lindsay M Fogel, Bianca DeAgresta, Maher Albitar, Tatyana Feldman, Lori Leslie, Andre Goy
{"title":"The clinical applications of next-generation sequencing and ctDNA/cfDNA in lymphoma.","authors":"Andrew Ip, Lindsay M Fogel, Bianca DeAgresta, Maher Albitar, Tatyana Feldman, Lori Leslie, Andre Goy","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Next-generation sequencing (NGS) technology plays a pivotal role in understanding the molecular landscape in oncology by providing a comprehensive analysis of genomic mutations. The detection and analysis of mutations have improved through tumor evaluation with various imaging techniques, tissue biopsies, and noninvasive liquid biopsy. NGS offers a multitude of diagnostic, prognostic, and management options that demonstrate a paradigm shift in how we care for patients with cancer. However, the roles of NGS and liquid biopsy in clinical practice still need to be standardized in protocols and guidelines so that they can be implemented broadly. Studies have shown promising evidence that liquid biopsy can be applied across the lymphoma landscape. These results demonstrate an expanding area of precision medicine research as oncology care continues to move toward minimally invasive and noninvasive genomic sequencing. The continued exploration of NGS in clinical practice may lead to more personalized therapeutic interventions in the hope of improving management, risk stratification, and outcomes in patients with lymphoma.</p>","PeriodicalId":51585,"journal":{"name":"Clinical Advances in Hematology & Oncology","volume":"24 1","pages":"14-21"},"PeriodicalIF":1.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146259967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adoptive cell therapy for ovarian cancer. 卵巢癌的过继细胞治疗。
IF 1.1
Clinical Advances in Hematology & Oncology Pub Date : 2026-01-01
Kunle Odunsi
{"title":"Adoptive cell therapy for ovarian cancer.","authors":"Kunle Odunsi","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":51585,"journal":{"name":"Clinical Advances in Hematology & Oncology","volume":"24 1","pages":"40-42"},"PeriodicalIF":1.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146259651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of menin inhibitors for acute leukemia. menin抑制剂在急性白血病中的应用。
IF 1.1
Clinical Advances in Hematology & Oncology Pub Date : 2026-01-01
Ghayas C Issa
{"title":"Use of menin inhibitors for acute leukemia.","authors":"Ghayas C Issa","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":51585,"journal":{"name":"Clinical Advances in Hematology & Oncology","volume":"24 1","pages":"37-39"},"PeriodicalIF":1.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146259938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Highlights in chronic lymphocytic leukemia from the 67th ASH Annual Meeting and Exposition. 来自第67届ASH年会和博览会的慢性淋巴细胞白血病的亮点。
IF 1.1
Clinical Advances in Hematology & Oncology Pub Date : 2026-01-01
{"title":"Highlights in chronic lymphocytic leukemia from the 67th ASH Annual Meeting and Exposition.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":51585,"journal":{"name":"Clinical Advances in Hematology & Oncology","volume":"24 1 Suppl 1","pages":"1-20"},"PeriodicalIF":1.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146259959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书